金佰利
KMB
105.57
+1.50
+1.44%
金佰利
US · KMB
#638 按市值排名
上市于 1970
105.57
+1.50
+1.44%
实时 - 追踪5344个代码 - 心跳于35秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了7家。
- 机构持股总比例下降了0.2个百分点。
机构持股
- 机构持股比例
- 98.90% -0.20pp
- 机构数量
- 1,948 -7
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund80.65%
Hedge Fund5.93%
Public Company5.59%
Private Company2.16%
Sovereign Wealth Fund1.76%
Government Pension Fund1.55%
Family Office/Trust0.52%
Insurance Company0.33%
Individual/Insider0.26%
Other1.23%
主要股东 截至 2026-06-30
BlackRock
9.72% · 32.32M 股
Vanguard Capital Management, LLC
7.08% · 23.54M 股
State Street Global Advisors
6.34% · 21.08M 股
Vanguard Portfolio Management, LLC
4.84% · 16.10M 股
FMR
3.50% · 11.65M 股
Geode Capital Management, LLC
3.37% · 11.20M 股
Charles Schwab Investment Management
3.25% · 10.81M 股
MFS Investment Management
2.45% · 8.16M 股
UBS Asset Management
2.33% · 7.75M 股
Two Sigma Investments, LP
2.12% · 7.05M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 28次买入 · 17次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Michael Hsu | Chairperson & CEO | 0.11% |
| Russell Torres | President of North America Consumer Business | 0.03% |
| Jeffrey Melucci | Chief Business Development & Legal Officer | 0.02% |
| Mae Jemison | Independent Director | 0.02% |
| Ehab Abou-Oaf | President of Kimberly-Clark Professional | 0.02% |
| Nelson Urdaneta | Senior Vice President | 0.01% |
| Tamera Fenske | Senior VP & Chief Supply Chain Officer | 0.01% |
| Sandra R. Karrmann | Chief Human Resources Officer | 0.01% |
| Christa Quarles | Independent Director | 0.00% |
| Zackery Hicks | Chief Digital & Technology Officer | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-31 | Suzana Blades | General Counsel | Initial Statement of Beneficial | 0 | -- |
| 2026-07-30 | Craig Slavtcheff | Chief Research & Development Officer | Derivative Exercise and Sale | -2,245 | $109.31 |
| 2026-07-30 | Craig Slavtcheff | Chief Research & Development Officer | Derivative Exercise and Retained | +3,034 | -- |
| 2026-07-30 | Patricia Aparecida Corsi | Global Chief Growth Officer | Derivative Exercise and Sale | -404 | $109.31 |
| 2026-07-30 | Patricia Aparecida Corsi | Global Chief Growth Officer | Derivative Exercise and Retained | +562 | -- |
| 2026-05-05 | Andrew Scribner | Vice President | Open Market Disposition | -4,095 | $98.00 |
| 2026-05-03 | Katy Chen | President of International Personal Care | Derivative Exercise and Sale | -1,596 | $95.34 |
| 2026-04-30 | Russell Torres | President of North America Consumer Business | Derivative Exercise and Sale | -2,876 | $97.67 |
| 2026-04-30 | Russell Torres | President of North America Consumer Business | Other Derivative Acquisition | +17,610 | -- |
| 2026-04-30 | Russell Torres | President of North America Consumer Business | Derivative Exercise and Retained | +4,428 | -- |
| 2026-04-30 | Jeffrey Melucci | Chief Business Development & Legal Officer | Derivative Exercise and Sale | -2,382 | $97.67 |
| 2026-04-30 | Jeffrey Melucci | Chief Business Development & Legal Officer | Other Derivative Acquisition | +13,924 | -- |
| 2026-04-30 | Jeffrey Melucci | Chief Business Development & Legal Officer | Derivative Exercise and Retained | +3,668 | -- |
| 2026-04-30 | Craig Slavtcheff | Chief Research & Development Officer | Derivative Exercise and Sale | -535 | $97.67 |
| 2026-04-30 | Craig Slavtcheff | Chief Research & Development Officer | Other Derivative Acquisition | +5,324 | -- |
| 2026-04-30 | Craig Slavtcheff | Chief Research & Development Officer | Derivative Exercise and Retained | +722 | -- |
| 2026-04-30 | Michael Hsu | Chairperson & CEO | Derivative Exercise and Sale | -8,505 | $97.67 |
| 2026-04-30 | Michael Hsu | Chairperson & CEO | Other Derivative Acquisition | +49,145 | -- |
| 2026-04-30 | Michael Hsu | Chairperson & CEO | Derivative Exercise and Retained | +13,107 | -- |
| 2026-04-30 | Nelson Urdaneta | Senior Vice President | Derivative Exercise and Sale | -2,646 | $97.67 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:28 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
金佰利 讨论区 0 条评论